SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Latigo Biotherapeutics Appoints Todd Smith President and CEO

Todd Smith replaces Nima Farzan, who resigned from the board and will transition to consulting.

LTGO

Related stories